BIT 2.53% 8.1¢ biotron limited

And, importantly; from Wednesday's annual report: "The Company...

  1. J8
    14,369 Posts.
    lightbulb Created with Sketch. 802
    And, importantly; from Wednesday's annual report:

    "The Company remains focused on achieving a commercial outcome for its antiviral programs in worldwide markets, including the USA, Europe and China. The major focus is on partnering the HIV-1 program. Meetings have been held with potential partners throughout the period under review, and further meetings are anticipated once the Company has data from the current HIV-1 clinical trial in hand."

    I don't expect a deal before the options expiry date. As far as I'm concerned, a deal will come from a result, but the SP will move enough to see the options over the line, without any issue.

    There are 500m on issue, plus 80m options to go.

    Let's say; ......to get the 6c options over the line we need to have a solid SP, probably close to 10c. Even @ 8c, for argument's sake, that's a market cap of circa $50m with cash of over $5m. A proven, potential adjunct for HIV should get to this sort of EV without a deal. I'm pretty sure they will be flogging the potential of Asian investment for other disease targets and getting on board with someone at the same time. This will keep the SP well and truly alive. A deal may come....... but we don't one yet, we need the right results.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.002(2.53%)
Mkt cap ! $73.08M
Open High Low Value Volume
7.5¢ 8.1¢ 7.2¢ $87.51K 1.177M

Buyers (Bids)

No. Vol. Price($)
2 30000 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 312790 2
View Market Depth
Last trade - 15.39pm 29/03/2024 (20 minute delay) ?
Last
7.7¢
  Change
0.002 ( 0.00 %)
Open High Low Volume
7.5¢ 8.0¢ 7.3¢ 161454
Last updated 15.34pm 29/03/2024 ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.